Approach to COVID-19 in older adults and indications for improving the outcomes.
Claudio TanaLivia MoffaKatia FalascaJacopo VecchietMarco TanaCesare MantiniFabrizio RicciAndrea TicinesiTiziana MeschiFrancesco CipolloneMaria Adele GiamberardinoPublished in: Annals of medicine (2023)
Background: COVID-19 continues to present challenges in the care of older adults with frailty and/or comorbidities and very old patients, who can be hospitalized with severe COVID-19 despite full vaccination. Frailty is a heterogeneous syndrome characterized by an increased aging-related vulnerability due to a reduced physiological reserve and function of systemic organs, and is associated with an impairment of activities of daily living. Frail older adults remain at elevated risk of mortality from COVID-19 compared to older adults without frailty, and some pre-existing risk factors such as malnutrition, prolonged bed rest, and the association with comorbidities can aggravate the SARS-CoV-2 infection. Furthermore, the severity of COVID-19 can impact on long-term functioning of older patients surviving from the infection. Persistent symptoms are another emerging problem of the post-vaccination phase of pandemic, as most patients suffer from chronic symptoms which can become debilitating and affect the daily routine. Aim of this review: In this complex relationship, the evaluation of COVID-19 in vulnerable categories is still a matter of high interest and personalized care plans based on a comprehensive geriatric assessment, tailored interventions; specific therapeutic algorithms among older adults are thus recommended in order to improve the outcomes.
Keyphrases
- coronavirus disease
- sars cov
- physical activity
- respiratory syndrome coronavirus
- risk factors
- healthcare
- community dwelling
- end stage renal disease
- ejection fraction
- machine learning
- climate change
- newly diagnosed
- prognostic factors
- deep learning
- chronic pain
- early onset
- pain management
- adipose tissue
- skeletal muscle
- patient reported outcomes
- affordable care act
- insulin resistance
- patient reported